AMSTELVEEN, Netherlands, Aug. 10, 2026 (GLOBE NEWSWIRE) — JBS N.V. (NYSE: JBS; B3: JBSS32), announces today its 2Q26 results. The numbers reported herein are in US dollars, in accordance with International Financial Reporting Standards (IFRS), unless otherwise specified. (in millions, except per share data)  Second Quarter   Six Months Ended    2026     2025   2Q26   2Q25Net Sales $ 23,900   $ 20,998   $ 45,508   $ 40,524Adjusted EBITDA (IFRS)¹ ² $ 1,429   $ 1,754   $ 2,563   $ 3,281Adjusted EBITDA (USGAAP)¹ ³ $ 1,257   $ 1,368   $ 2,173   $ 2,681Adjusted Operating Income (IFRS)¹ ² $ 790   $ 1,188   $ 1,306   $ 2,181Adjusted Operating Income (USGAAP)¹ ³ $ 866   $ 1,034   $ 1,410   $ 2,033Net Income Attributable to JBS² $ -102   $ 528   $ 118   $ 1,028Earnings Per Share Attributable to JBS² $ -0.10   $ 0.48   $ 0.11   $ 0.93Adjusted...

ORLANDO, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenue for the quarter ended June 30, 2026 of $33,805,000 compared with $26,986,000 net revenue for the quarter ended June 30, 2025. The increase in net revenue was primarily due to an increase in contract equipment revenues recognized over time and associated freight revenue. As a percent of net revenue, gross profit margins increased 140 basis points to 27.9% in the quarter ended June 30, 2026, compared to 26.5% in the quarter ended June 30, 2025. Product engineering and development expenses decreased $61,000 to $680,000 for the quarter ended June 30, 2026, as compared to $741,000 for the quarter ended June 30, 2025 due to lower headcount. Selling, general and administrative (“SG&A”)...

SALT LAKE CITY, Aug. 10, 2026 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”), please note that in the first paragraph below the tables, the book value per common share as of June 30, 2026 should be $16.63, not $15.45 as previously stated; and in the second paragraph below the tables, the number of Class A equivalent shares outstanding as of June 30, 2026 should be 26,034,378, not 28,034,378 as previously stated. The corrected release follows: Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced financial results for the quarter ended June 30, 2026. For the three months ended June 30, 2026, SNFC’s after-tax earnings increased 7.3% from $8,371,000 in 2025, to $8,982,000 in 2026....

Strong operating performance driven by an increase in industrial occupancy(1) to 97% TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) — Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the second quarter ended June 30, 2026. “We achieved several significant milestones second quarter, and I am incredibly pleased, as we advance our journey as Canada’s industrial building partner,” said Kelly Hanczyk, CEO of Nexus Industrial REIT. “We made significant advancements in our leasing, completing 380,000 sq. ft. of renewals with an average lift of 6%, and growing industrial occupancy(1) to a healthy 97%. We sold our share of an inactive development project, generating proceeds of $14 million, and at the beginning of the quarter, we achieved an investment grade credit rating and completed an inaugural $500 million...

 Company establishes structural cost reduction targets, further refines transformational pillars SUGAR LAND, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary inspection, heat-treating, and mechanical services, today reported its financial results for the quarter ended June 30, 2026. The Company also provided guidance for the full year 2026. Second Quarter 2026 Highlights:Reported revenue of $228.7 million, compared to $248.0 million in the second quarter of 2025. Generated gross margin of $54.4 million, compared to $68.1 million in the second quarter of 2025. Reported a net loss of $6.8 million, compared to a net loss of $4.3 million in the...

Generated revenue of approximately $30 million, up 5% Reported Adjusted EBITDA(1) of approximately $5.8 million, up 59% on prior year period 9th consecutive quarter of positive Adjusted EBITDA, driven by foundational PAC business Gross margin improved to 38.5%, an increase of 520 bps over prior year Reaffirmed full-year 2026 guidance of $120-125 million revenue and $17-20 million Adjusted EBITDA GREENWOOD VILLAGE, Colo., Aug. 10, 2026 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (the “Company” or “Arq”), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced its financial and operating results for the quarter ended June 30, 2026. Financial HighlightsGenerated revenue of $29.9 million in Q2 2026 versus $28.6 million...

IRVINE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) — Phoenix Energy One, LLC (NYSE American, PHXE.P) (“Phoenix Energy” or the “Company”), an energy company focused on oil and gas exploration and production across key U.S. basins, today reported its financial and operating results for the second quarter ended June 30, 2026 on Form 10-Q with the U.S. Securities and Exchange Commission. Q2 2026 HighlightsGenerated total revenues of $405.9 million in Q2 2026 as compared to $163.8 million in Q2 2025, net income of $106.0 million as compared to $18.7 million in Q2 2025, EBITDA of $238.4 million as compared to $92.0 million in Q2 2025, and Adjusted EBITDA of $181.3 million as compared to $84.3 million in Q2 2025. Cash flow provided by operating activities was $277.3 million for the six months ended June 30, 2026, as compared to $100.6 million...

Driving Growth: Expanded Margins, Higher Positive Earnings, Strengthened Balance Sheet, and Raised Revenue Guidance ROCHESTER, NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of deep tech for the defense, space, AI data center, and other vibrant end-markets, today reported financial results for the second quarter ended June 30, 2026, where Defense and Space Tech product lines ramped to drive all-time high revenue, margin expansion, and increased earnings. Syntec products have a typical 6-8 year life cycle and yearly recurring revenues. Earnings Call information: Date: Wednesday, August 12, 2026 Time: 5:00 p.m. ET Register in Advance (Required): https://us06web.zoom.us/meeting/register/dw9jrC8DSaW4EzSyA1vFAQ (After registering, you will receive a confirmation email containing...

Advancing VMT-α-NET toward a Phase 3 study in neuroendocrine tumors, subject to regulatory alignment: regulatory engagement ongoing; clinical site activation targeted around year-end 2026 subject to regulatory feedback; sufficient isotope access and manufacturing capacity VMT-α-NET study update accepted for oral presentation at ESMO 2026 VMT01 melanoma and PSV359 FAP-α clinical programs continue to advance Approximately $237 million in cash, cash equivalents, and short-term investments as of June 30, 2026; expected to be sufficient to fund current planned clinical milestones and operational investments into late 2027SEATTLE, Aug. 10, 2026 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced...

Initiated a Phase 1 study of SCY-770, a first-in-class, potent and direct AMPK activator for treatment of ADPKD; topline data are expected in Q3 2026 and are anticipated to inform dose selection for the planned Phase 2 studyThe Phase 2 proof-of-concept study of SCY-770 in patients with ADPKD remains on track for initiation in Q4 2026, with an early efficacy read-out expected in the second half of 2027Completed dosing in the Phase 1 study of the IV formulation of second-generation antifungal SCY-247, with topline data on track for Q3 2026Ended Q2 2026 with cash, cash equivalents and investments of $71.1 million, supporting a cash runway into 2029JERSEY CITY, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a clinical-stage biotechnology company dedicated to advancing innovative...